Clinical Trial Update: Microneedle Patch With Botulinum Toxin in Management of Enlarged Facial Pores [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating a microneedle patch delivering botulinum toxin for managing enlarged facial pores.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enlarged Pores

Drugs mentioned

• Microneedle Patch With Botulinum Toxin

Snippet

Sponsor: Dhurakij Pundit University | Conditions: Enlarged Pores | Phase 3 | Status: UNKNOWN